Pharmacogenomics (journal)

Not to be confused with The Pharmacogenomics Journal.

Pharmacogenomics is a peer-reviewed medical journal established in 2000 and published by Future Medicine. The editors-in-chief are David Gurwitz (Tel-Aviv University), Howard McLeod (University of North Carolina at Chapel Hill), and Munir Pirmohamed (University of Liverpool). The journal covers the field of pharmacogenomics.

Pharmacogenomics

Discipline	Pharmacogenomics
Language	English
Edited by	David Gurwitz, Howard McLeod, Munir Pirmohamed
Publication details
History	2000–present
Publisher	Future Medicine Ltd
Frequency	18/year
Impact factor	2.350 (2016)
Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt )
ISO 4	Pharmacogenomics
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus · W&L
CODEN	PARMFL
ISSN	1462-2416 (print) 1744-8042 (web)
OCLC no.	55059877
Links
Journal homepage

Abstracting and indexing

The journal is abstracted and indexed in Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index, Chemical Abstracts, Current Contents/Life Sciences, EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index, and Scopus. According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.350, ranking it 132nd out of 256 journals in the category "Pharmacology & Pharmacy".^[1]